Acurx Pharmaceuticals Inc. (ACXP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acurx Pharmaceuticals Inc...

    NASDAQ: ACXP · Real-Time Price · USD
    4.59
    0.03 (0.66%)
    At close: Oct 03, 2025, 3:56 PM
    4.55
    -0.87%
    After-hours: Oct 03, 2025, 05:39 PM EDT

    Acurx Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -14.1M -14.58M -12.09M -12.75M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 3.44M 3.77M 3.3M 6.74M
    Other Working Capital
    		 206.06K 1.14M 1.25M 141.28K
    Other Non-Cash Items
    		 n/a n/a n/a 850.26K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 284.09K 1.01M 1.25M 141.28K
    Operating Cash Flow
    		 -10.38M -9.8M -7.54M -5.01M
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 210.2K 2.22M 13.00 n/a
    Financial Cash Flow
    		 6.62M 8.16M 3.7M 14.8M
    Net Cash Flow
    		 -3.77M -1.64M -3.85M 9.78M
    Free Cash Flow
    		 -10.38M -9.8M -7.54M -5.01M

    Add to Watchlist